IASLC 2019 Small Cell Lung Cancer Meeting focuses on immunotherapy and patient perspective

While non-small cell lung cancer is the more common form of lung cancer and attracts the lion’s share of the research funding, recent developments in small cell lung cancer may be shifting that slightly.

From https://www.news-medical.net/news/20190329/IASLC-2019-Small-Cell-Lung-Cancer-Meeting-focuses-on-immunotherapy-and-patient-perspective.aspx

from
https://healthnews010.wordpress.com/2019/03/30/iaslc-2019-small-cell-lung-cancer-meeting-focuses-on-immunotherapy-and-patient-perspective/

From https://heidifrost.blogspot.com/2019/03/iaslc-2019-small-cell-lung-cancer.html

from
https://heidifrost0.wordpress.com/2019/03/30/iaslc-2019-small-cell-lung-cancer-meeting-focuses-on-immunotherapy-and-patient-perspective/

From https://kathrynhenson0.blogspot.com/2019/03/iaslc-2019-small-cell-lung-cancer.html

from
https://kathrynhenson0.wordpress.com/2019/03/30/iaslc-2019-small-cell-lung-cancer-meeting-focuses-on-immunotherapy-and-patient-perspective/

From https://kathleenwood0.blogspot.com/2019/03/iaslc-2019-small-cell-lung-cancer.html

from
https://kathleenwood0.wordpress.com/2019/03/30/iaslc-2019-small-cell-lung-cancer-meeting-focuses-on-immunotherapy-and-patient-perspective/